For the quarter ending 2026-03-31, ARCT has $245,411K in assets. $54,049K in debts. $211,375K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Restricted cash | - | - | 55,000 | 55,000 |
| Cash and cash equivalents | 211,375 | 230,909 | 180,360 | 196,467 |
| Accounts receivable | 1,343 | 5,564 | 7,951 | 17,204 |
| Prepaid expenses and other current assets | 4,164 | 4,973 | 5,889 | 5,832 |
| Total current assets | 216,882 | 241,446 | 249,200 | 274,503 |
| Property and equipment, gross | 19,017 | 19,227 | 19,390 | - |
| Less accumulated depreciation and amortization | 12,939 | 12,491 | 11,971 | - |
| Property and equipment, net | 6,078 | 6,736 | 7,419 | 8,088 |
| Operating lease right-of-use assets, net | 20,423 | 21,081 | 23,839 | 24,794 |
| Non-current restricted cash | 2,028 | 1,885 | 1,885 | 1,885 |
| Total assets | 245,411 | 271,148 | 282,343 | 309,270 |
| Accounts payable | 4,093 | 4,235 | 5,491 | 10,623 |
| Accrued liabilities | 22,666 | 23,898 | 19,382 | 24,629 |
| Deferred revenue | 7,610 | 8,246 | 6,826 | 11,263 |
| Total current liabilities | 34,369 | 36,379 | 31,699 | 46,515 |
| Deferred revenue, net of current portion | - | - | 4,220 | 8,769 |
| Operating lease liability, net of current portion | 19,680 | 20,784 | 21,865 | 22,933 |
| Total liabilities | 54,049 | 57,163 | 57,784 | 78,217 |
| Common stock, 0.001 par value 60,000 shares authorized issued and outstanding shares were 28,423 at march 31,2026 and 28,414 at december 31, 2025 | 28 | 28 | 27 | 27 |
| Additional paid-in capital | 732,888 | 728,547 | 710,043 | 703,089 |
| Accumulated deficit | -541,554 | -514,590 | -485,511 | -472,063 |
| Total stockholders equity | 191,362 | 213,985 | 224,559 | 231,053 |
| Total liabilities and stockholders equity | 245,411 | 271,148 | 282,343 | 309,270 |
Arcturus Therapeutics Holdings Inc. (ARCT)
Arcturus Therapeutics Holdings Inc. (ARCT)